Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
1(9%)
Results Posted
71%(5 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_2
5
45%
Ph not_applicable
4
36%
Ph phase_3
1
9%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
5(45.5%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
4(36.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(7)
Terminated(2)

Detailed Status

Completed7
Terminated2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
77.8%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (9.1%)
Phase 25 (45.5%)
Phase 31 (9.1%)
N/A4 (36.4%)

Trials by Status

completed764%
not_yet_recruiting19%
recruiting19%
terminated218%

Recent Activity

1 active trials
Showing 5 of 11
completednot_applicable

Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region

NCT02780648
recruitingphase_3

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

NCT03895359
completedphase_2

Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas

NCT01595321
not_yet_recruitingphase_2

SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer

NCT06422156
completedphase_2

Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)

NCT00914355
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT02780648Not Applicable

Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region

Completed
NCT03895359Phase 3

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

Recruiting
NCT01595321Phase 2

Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas

Completed
NCT06422156Phase 2

SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer

Not Yet Recruiting
NCT00914355Phase 2

Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)

Completed
NCT00914615Phase 2

Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3)

Completed
NCT00832780Not Applicable

Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung

Completed
NCT01051037Not Applicable

Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways

Completed
NCT00243841Not Applicable

Dose Escalation Study for Primary Hepatocellular Carcinoma

Completed
NCT01439542Phase 2

FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer

Terminated
NCT00672178Phase 1

Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC)

Terminated

All 11 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
11